ROPIVACAINE HYDROCHLORIDE

Generic: ROPIVACAINE HYDROCHLORIDE

Eugia US LLCManufacturer
EPIDURAL, INFILTRATION, PERINEURALRoute
ROPIVACAINE HYDROCHLORIDEActive Substance
2016-07-13Original Approval

ROPIVACAINE HYDROCHLORIDE is FDA application ANDA205612, sponsored by EUGIA PHARMA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Recalls

Top Reported Reactions

1
VOMITING
604 reports
2
PNEUMONIA
598 reports
3
DRUG HYPERSENSITIVITY
594 reports
4
OEDEMA
589 reports
5
DYSPNOEA
581 reports
6
ASTHMA
566 reports
7
WHEEZING
554 reports
8
PAIN
250 reports
9
MALAISE
233 reports
10
RESPIRATORY TRACT INFECTION
222 reports